INTRODUCTION
The exposure of cells to ionizing radiation results in complex cellular responses resulting in cell death and altered proliferation states. The underlying cytotoxic, cytoprotective and cellular stress responses to radiation are mediated by existing signaling pathways, the activation of which may be amplified by intrinsic cellular radical production systems. 1) Tyrosine kinases are critical components of signaling pathway that control cellular proliferation and differentiation.
2) Several studies indicate that ionizing radiation stimulates tyrosine specific protein kinases in human B-lymphocyte precursors, triggering apoptosis and clonogenic death.
3) It has been reported that the inducible expression of dominant-negative epidermal growth factor receptor-CD533 results in a radiosensitization of human mammary carcinoma cells. 4) PKC also plays a pivotal role in radiation-induced cellular responses. 5) It has been observed that the phosphorylation capacity of PKC increases 5-fold within 15 s of X-irradiation, and PKC-specific substrates are subsequently phosphorylated. 6) Furthermore, PKC gene expression is increased soon after irradiation. 7) The activation of PKC is known to confer a radioresistance on tumor cells and inhibitors of PKC to induce radiosensitivity. 8) MAP kinases have been known to play the role in cytotoxic, cytoprotective, and cellular stress responses to irradiation.
1) It has been demonstrated in human U-937 myeloid leukaemia cells that MAP kinase p44/42 is activated at 20 Gy following 30 min of X-irradiation. 9) It has been demonstrated that the downregulation of ERK2 is essential for the inhibition of radiation-induced cell death in HSP25 overexpressed L929 cells. 10) Most studies, except for a few are done on single cells; thus only a paucity of data exists where signaling following whole-body irradiation is concerned. The response of the signaling molecule may differ in in vitro and in vivo conditions. This has been well documented in regard to NF-κB, where following irradiation the activation of NF-κB had been observed in many tissues in culture. 11) However, variations in vivo have subsequently been reported where NF-κB was seen be activated at a lower dose of 8.5 Gy of γ-irradiation.
12)
The present study was carried out to clarify whether the response of the three kinases viz. tyrosine kinase, PKC, and MAP kinase was different in in vivo and ex vivo conditions following γ-irradiation and also to study the dose-dependent responses of these enzymes. therapy unit at a rate of 78.60-cGy min -1 . Three mice in each group were irradiated at various doses from 0. 
Lymphocyte isolation for ex vivo experiments
Blood was quickly collected by puncturing the heart of mice sacrificed by cervical dislocation with a 2.9 gauge (Becton Dickinson, USA) needle and collected in tubes containing 3.8% sodium citrate in ice-cold PBS in a ratio 1:1 v/v. Blood was layered over cold Histopaque in a ratio 1:2 centrifuged at 1,500 rpm for 10 min at 4°C. 13) A lymphocyte layer (buffy coat) was immediately suspended in an ice-cold buffer containing 10 mM HEPES, 0.25 M sucrose, 5 mM EDTA, 5 mM EGTA, 2 mM PMSF, 1 mM leupeptin, 10 µg ml -1 aprotinin, and 10 µg ml -1 pepstatin (pH 7.5) 14) and given 2 × 3 min washes at 4°C at 1,200 rpm. Lymphocytes were then irradiated at 0.1-3.0 Gy and incubated at 37°C for 30 min. Lymphocytes were then lysed in 200 µl of cold buffer by use of a minisonication probe, with 10 bursts at 50% output control and 50% duty cycle. The whole lysate was quick-frozen in liquid N2 and stored at -70°C. The lysate was quick frozen in liquid N2 and stored at -70°C to be used for tyrosine kinase, PKC, and MAP kinase assays.
Lymphocyte isolation for in vivo experiments
The mice were irradiated at 0.1-3.0 Gy, then sacrificed 30 min postirradiation. Lymphocytes were isolated as described for ex vivo experiments. For in vivo experiments, the maximum number of samples handled at a time was only two to keep the time taken from isolation to lyses to a minimum.
The flowchart for the above is as follows
The lymphocyte lysates thus prepared following in vivo and ex vivo were then used for the tyrosine kinase, PKC, and MAP kinase assays.
Estimation of tyrosine kinase, protein kinase C, and MAP kinase activities
The activities of tyrosine kinase, protein kinase C, and MAP kinase were estimated in lymphocytes. The tyrosine kinase activity was estimated in the plasma membrane (40 µg) in a reaction mixture containing 20 mM TEA (pH 7.5), 50 mM NaF, 1mM DTT, and 1 mg/ml Glu80 Tyr20 according to Chan et al. 15) The reaction was initiated by an addition of γ[
6 cpm/tube). After incubation at 37°C for 15 min, 25 µl aliquots were spotted on Whatmann 3 MM filter paper and washed with cold 10% TCA plus 8% pyrophosphate. The strips were dried and counted.
PKC activity in lymphocytes was determined by the modification of the mixed micelle assay 16) and the protocol supplied by Amersham Pharmacia Biotech of the UK with the assay kit was followed. Each reaction mixture (75 µl) contained 50 mM Tris HCl (pH 7.5), 2.5 mM DTT, 12.5 µM ATP, 3.75 mM Mg min. An aliquot was spotted on filter paper disc, which was washed in 75 mM orthophosphoric acid and counted.
MAP kinase activity was estimated in lymphocytes. It was assayed with a kit provided by Amersham Pharmacia Biotech of the UK. Each reaction mixture contained 10 µl peptide in HEPES, sodium orthovanadate, and 0.005% sodium azide (pH 7.4), 5 µl Mg ATP, 10 µg enzyme protein, 1 µCi γ [ 32 P]ATP. The reaction was carried out for 30 min at 30°C. An aliquot was spotted on filter paper disc, and washed with 75 mM orthophosphoric acid, and counted. For all the above assays, radioactivity was counted in an LKB Rackbeta 1217 liquid scintillation spectrometer. Protein estimation was done by the method of Lowry et al.
17)

Ex vivo isolation
In vivo isolation Mice sacrificed Mice irradiated at different doses and sacrificed after 30 min. 60-70 µl blood/mice withdrawn in 2 min + cold PBS with 3.8% sodium citrate 60-70 µl blood/mice withdrawn in 2 min + cold PBS with 3.8% sodium citrate Layered on cold Histopaque-centrifuged at 1,500 rpm for 10 min at 4°C.
Layered on cold Histopaque-centrifuged at 1,500 rpm for 10 min at 4°C. Lymphocyte layer suspended in cold buffer-2 × 3 min washes at 1,200 rpm at 4°C.
Lymphocyte layer suspended in cold buffer-2 × 3 min washes at 1,200 rpm at 4°C. Lymphocytes irradiated at different doses and incubated for 30 min at 37°C.
Lymphocytes were lysed by sonication.
Lymphocytes were lysed by sonication
RESULTS
The activity of tyrosine kinase, protein kinase C, and MAP kinase was looked for at various doses from 0.1 Gy-3 Gy in mouse lymphocytes after 30 mins of irradiation. The lymphocytes were isolated at 30 min postirradiation for ex vivo experiments; for in vivo experiments lymphocytes were first isolated and then irradiated. The study was carried out with a view to establish the difference, if any, in the response of the above enzymes in ex vivo and in vivo conditions.
An increase was observed in the tyrosine kinase activity in the lymphocytes irradiated ex vivo; the activity was seen to increase with an increasing dose to 1 Gy, then decreased at 3 Gy. In vivo tyrosine kinase activity exhibited a pattern similar to ex vivo tyrosine kinase response. Therefore, no difference could be seen in the expression of tyrosine kinase activity in ex vivo or in vivo (Fig. 1) .
PKC exhibited a difference in the dose at which it was activated in in vivo and ex vivo conditions. PKC was seen to be maximally activated at the higher dose (1 Gy) in ex vivo irradiated lymphocytes, whereas in in vivo irradiated lymphocytes, PKC was seen to be activated at a much lower dose (0.1 Gy) (Fig. 2) .
A significant difference was seen in the activation of MAP kinase activity in lymphocytes irradiated in ex vivo and in vivo. In ex vivo irradiated lymphocytes, MAP kinase activity was seen to increase with an increasing dose and was found to reach a maximum at 3 Gy. MAP kinase activity in in vivo irradiated lymphocytes was seen to decrease as the dose was increased, and minimum activation was also at 3 Gy (Fig. 3) .
Of the three enzymes, PKC activity exhibited a dose-dependent difference, MAP kinase was found to behave totally differently in in vivo and ex vivo conditions, but no difference was observed in the response of tyrosine kinase.
DISCUSSION
Although there are various reports on the activation of tyrosine kinases, these are all in vitro studies. 18) Therefore we carried out studies on the response of tyrosine kinase in lymphocytes irradiated in ex vivo and in vivo to see whether the response of the above enzyme differed under ex vivo and in vivo conditions. It is interesting that no difference was observed in the response of tyrosine kinase in either condition (Fig. 1) .
The activation of PKC, a very crucial enzyme in signaling, has been reported in various cell lines following γ-irradiation. 19) In our previous studies we have observed the activation of PKC in hepatocytes after 30 min of irradiation. 20) The activation of PKC seen in ex vivo and in vivo was found to be dose-dependent (Fig. 2) . The differential activation of PKC could be due to the changes in the ex vivo environment and the lack of interaction with the other cells. Lymphocytes irradiated in vivo are subject to all the physiological and biochemical constraints that an ex vivo lymphocyte or cell is not subjected to.
MAP kinase plays a central role in various signal transduction pathways, and its activation has been reported in NIH 3T3 cells by irradiation through the formation of reactive oxygen intermediates. 21) and a radiation-induced translocation of the enzyme from cytosol to nucleus in Chinese Hamster V79 cells. 22) We have observed a significant difference in the activity of MAP kinase following ex vivo and in vivo irradiation of lymphocytes (Fig. 3) . In in vivo irradiated lymphocytes, MAP p42/p44 activity was seen to increase with an increasing dose with maximum activation at 3 Gy, whereas the activity of the enzyme decreased as the dose increased in ex vivo irradiated lymphocytes. These results are supported by earlier studies that MEK pathway substrate p42/p44 (Erk), known to be involved in the radiation, induced cytoprotective pathways leading to the development of radioresistance of tumors. 23, 24) Other signaling factors such as NFκβ are also known to be crucial to the development of radioresistance, 25) for which the differential expression in various tissues has been reported. 26) Thus in conclusion it can be summarized that the response of these enzymes in situ may be very different from an isolated cell. In whole body γ-irradiation, as is known, the response varies from organ to organ. Moreover, the pathways that operate in situ in a whole animal, where various biochemical and physiological constraints are operative, may not operate in a single irradiated cell. In recent years these signaling molecules have been increasingly used for manipulating tumor response to radiotherapy. 27) Thus for the better management of these signaling molecules for clinical advantage, it is necessary to study the behavior of these molecules at lower doses that are therapeutically relevant and in the whole animal. This study conclusively shows that data obtained from ex vivo irradiation or obtained at high doses of radiation should not be extrapolated to in vivo conditions, especially where the data have to be clinically deployed.
